Seattle-area microbiome and diagnostics startup Viome Life Sciences is elevating extra cash, in accordance with a brand new regulatory submitting.
The submitting reveals $67 million raised of a bigger spherical. We’ve reached out to Viome to study extra and can replace once we hear again. Replace: Viome corroborated the funding quantity in an announcement Tuesday.
Viome sells a package to find out the microbial composition of stool samples and recommends “precision” dietary supplements and probiotics based mostly on a person’s readout. This July, the corporate launched a “Full Physique Intelligence Check” that additionally analyzes saliva and blood samples. Earlier this yr celeb and socialite Paris Hilton turned a Viome model ambassador.
The corporate can also be creating a diagnostic check for oral and throat most cancers that has obtained breakthrough machine designation from the FDA, enabling it to obtain expedited evaluation previous to approval.
In April 2021, the six-year previous firm stated it had greater than 200,000 clients and was anticipating income to hit $100 million in 2022.
Viome is the seventh enterprise of founder and CEO Naveen Jain. Jain is the founder and former CEO of InfoSpace and likewise co-founded public data agency Intelius, in addition to Moon Specific, which goals to take paying clients to the moon.
Viome raised $54 million raised in November, bringing its whole funding to greater than $125 million.
Viome’s earlier buyers embody Khosla Ventures, WestRiver Group, Glico, Doctor Companions, Ocgrow Ventures and Daring Capital Group. All these buyers participated within the new funding spherical, which was led by Daring Capital. Salesforce CEO Marc Benioff was an early investor within the firm.
Conclusion: So above is the Naveen Jain’s microbiome and diagnostics startup Viome is elevating extra cash article. Hopefully with this article you can help you in life, always follow and read our good articles on the website: Surprise-cafe.com
